Eli Lilly and Co (LLY)
731.88
-13.81
(-1.85%)
USD |
NYSE |
Apr 24, 16:00
724.60
-7.28
(-0.99%)
After-Hours: 20:00
Eli Lilly Free Cash Flow (Quarterly): -1.963B for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.963B |
| September 30, 2023 | -1.812B |
| June 30, 2023 | -204.40M |
| March 31, 2023 | 827.10M |
| December 31, 2022 | 1.024B |
| September 30, 2022 | 1.565B |
| June 30, 2022 | 369.70M |
| March 31, 2022 | 1.642B |
| December 31, 2021 | 1.762B |
| September 30, 2021 | 1.176B |
| June 30, 2021 | 1.244B |
| March 31, 2021 | 1.205B |
| December 31, 2020 | 995.70M |
| September 30, 2020 | 1.392B |
| June 30, 2020 | 1.972B |
| March 31, 2020 | 111.10M |
| December 31, 2019 | 1.637B |
| September 30, 2019 | 1.169B |
| June 30, 2019 | 766.20M |
| March 31, 2019 | -89.30M |
| December 31, 2018 | 825.00M |
| September 30, 2018 | 1.822B |
| June 30, 2018 | -340.70M |
| March 31, 2018 | 200.00M |
| December 31, 2017 | 1.25B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.433B |
| June 30, 2017 | 1.430B |
| March 31, 2017 | -660.90M |
| December 31, 2016 | 1.542B |
| September 30, 2016 | 1.434B |
| June 30, 2016 | 1.156B |
| March 31, 2016 | -373.40M |
| December 31, 2015 | 441.90M |
| September 30, 2015 | 781.20M |
| June 30, 2015 | 588.70M |
| March 31, 2015 | -473.40M |
| December 31, 2014 | 673.80M |
| September 30, 2014 | 1.349B |
| June 30, 2014 | 799.00M |
| March 31, 2014 | 70.30M |
| December 31, 2013 | 1.182B |
| September 30, 2013 | 1.738B |
| June 30, 2013 | 1.501B |
| March 31, 2013 | 221.50M |
| December 31, 2012 | 1.152B |
| September 30, 2012 | 1.328B |
| June 30, 2012 | 1.092B |
| March 31, 2012 | 688.20M |
| December 31, 2011 | 1.662B |
| September 30, 2011 | 1.725B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.963B
Minimum
Dec 2023
1.972B
Maximum
Jun 2020
783.09M
Average
1.169B
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| Amgen Inc | 289.00M |
| Biogen Inc | -52.70M |
| Madrigal Pharmaceuticals Inc | -80.97M |
| Vertex Pharmaceuticals Inc | 118.50M |
| Viking Therapeutics Inc | -17.64M |